By eliapharma | July 13, 2009 at 10:48 PM EDT | No Comments
Welcome to our blog.
Dear Clients, we are in the process of validating our analytical methods.
The first analysis will start on the 21 March 2011.
Best regards,
Samir Nassr, CEO
Latest Top (5) News
Santarus to present UCERIS Phase III trial data on ulcerative colitis at DDW meeting Santarus, Inc. today announced that safety and efficacy data from a Phase III, double-blind, multicenter, placebo-controlled 12 month extended use study with the investigational drug UCERIS (budesonide) 6 mg tablets will be featured in four poster presentations at the Digestive Disease Week (DDW) Meeting being held at the San Diego Convention Center on May 19 - 22, 2012.
Sat, 19 May 2012 07:01:22 -0400 Receptos to present scientific podium presentation about RPC1063 at DDW 2012 Receptos Inc. today announced that company personnel will deliver a scientific podium presentation about RPC1063 at the Digestive Disease Week (DDW) annual meeting at 9 a.m. PDT on Sunday, May 20, 2012 at the San Diego Convention Center in San Diego, California. DDW attracts thousands of physicians, researchers, and academics from around the world to share the latest research in gastrointestinal health topics, for which DDW is the premier scientific conference.
Sat, 19 May 2012 06:56:33 -0400 Ceregene announces new data from CERE-120 clinical trial on Parkinson's Ceregene Inc., a biotechnology company developing treatments for neurodegenerative diseases such as Parkinson's disease, will present new data demonstrating long-term, biologically-active expression of neurturin, a nervous system growth factor delivered to the degenerating dopamine nerves in patients with Parkinson's disease following treatment with CERE-120.
Sat, 19 May 2012 06:54:37 -0400 Quest Diagnostics introduces four new tests panels for CAH Quest Diagnostics, the world's leading provider of diagnostic testing, information and services, has extended its endocrine diagnostics menu with the introduction of four new tests panels for congenital adrenal hyperplasia (CAH), an endocrine disorder found in newborns, children and women.
Sat, 19 May 2012 06:49:17 -0400 LKCF, Spirit of Women’s HeartCaring to help reduce disparities in diagnosis and care In an ongoing effort to save the lives of thousands of Americans at risk of cardiovascular ailments each year, Spirit of Women Health Network has joined forces with the Larry King Cardiac Foundation (LKCF) to help reduce the devastating disparity in the diagnostics, clinical care, and survival rate of heart attacks, strokes and other heart events for women and people of color.
Vertex established a research site in Laval, Quebec in 2009, and since that time, many scientists have been focused on IBD research, among other discovery and development activities for Vertex.
A two-day symposium offering a ground-breaking program.
Take part in an exciting program focused on the latest innovations in life sciences in terms of R&D, regulations, new technologies, business strategies and financing models.